Aehr Test Systems, Inc. (AEHR) Q3 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The financial performance shows strong growth with an 18% increase in revenue and a 25% rise in net income, driven by strong demand and operational efficiencies. Gross margin improvement and positive cash flow further support a positive outlook. Despite the lack of strategic and operational updates, the financial results suggest a positive sentiment for the stock over the next two weeks.
Key Financial Performance
Revenue $22.3 million, up 18% year-over-year, driven by strong demand for our wafer-level test and burn-in systems.
Gross Margin 50.2%, an increase from 48.5% year-over-year, attributed to improved operational efficiencies and favorable product mix.
Net Income $4.5 million, up 25% year-over-year, due to higher revenue and better cost management.
Operating Expenses $6.8 million, up 10% year-over-year, primarily due to increased R&D investments and higher personnel costs.
Cash Flow from Operations $5.2 million, an improvement from $4.0 million year-over-year, reflecting stronger collections and operational performance.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Blair LLC
CEO Director
CFO Executive
Capital Group
Capital LLC
Capital Markets
Chlebina Capital
Chris Siu
Christian Schwab
Conference Instructions
Director Chris
Division Christian
Division Lake
Division Larry
EDT PondelWilkinson
Executive VP
Finance
Inc Greetings
Inc President
LLC PM
LLC Research
Lake Street
Larry Chlebina
Markets LLC
PM EDT
Relations today
Research Division
Schwab Craig
Secretary Shooter
Shooter Blair
Siu CFO
Street Capital
Systems Inc
host PondelWilkinson
AEHR Transcript
Aehr Test Systems, Inc. (AEHR) Q3 2026 Earnings Call Transcript
Positive4-7
The financial performance shows strong growth with an 18% increase in revenue and a 25% rise in net income, driven by strong demand and operational efficiencies. Gross margin improvement and positive cash flow further support a positive outlook. Despite the lack of strategic and operational updates, the financial results suggest a positive sentiment for the stock over the next two weeks.
Aehr Test Systems, Inc. (AEHR) Q2 2026 Earnings Call Transcript
Unknown1-8
The earnings call reveals a significant decline in revenue and gross margin, with a net loss reported. Management's vague responses in the Q&A add uncertainty. Despite positive long-term prospects in AI and strategic partnerships, the immediate financial performance and unclear guidance suggest a negative market reaction. Additionally, the potential cannibalization of existing products and delays in benchmarks add to investor concerns.
Aehr Test Systems, Inc. (AEHR) Q1 2026 Earnings Call Transcript
Unknown10-6
The earnings call revealed a significant decline in revenue and gross margin, with no clear timeline for improvement in AI growth opportunities. The Q&A session highlighted management's reluctance to provide specific guidance, creating uncertainty. Despite some optimism in product development and market expansion, the lack of immediate orders and declining financial metrics suggest a likely negative market reaction.
Aehr Test Systems, Inc. (AEHR) Q4 2025 Earnings Call Transcript
Unknown7-8
The earnings call reveals several negative factors: a significant decline in gross margins, a non-GAAP net loss, and a substantial drop in cash reserves due to acquisitions and overhead costs. The withdrawal of revenue guidance adds uncertainty, and while AI market potential is noted, it is offset by current financial struggles. The Q&A highlights management's vague responses about future prospects and the impact of external factors, further adding to investor concerns. Despite some positive aspects, such as AI market growth, the overall sentiment leans negative due to financial and operational challenges.
AEHR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
